Your session is about to expire
← Back to Search
Study Summary
This trial will test whether CBD can help with insomnia in people with HIV. It will last 5 weeks and use daily doses of CBD between 50mg and 600mg.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am an adult with sleep problems, regardless of my HIV status.You have used marijuana, CBD, or other similar substances in the past 30 days.You have had a serious problem with drugs or alcohol in the past year.I am not pregnant, breastfeeding, and willing to prevent pregnancy during the trial.My high blood pressure is not under control.I do not have any health conditions that could interfere with the study.I am willing to stop taking sleep or anxiety medication.I do not have a neurological condition that could affect study results.I have a long-term lung condition.I am fluent in English or Spanish.I have used sedatives for reasons other than sleep or abused them in the last year.You have used drugs or alcohol in excess in the last 30 days.I am at risk for heart disease.I have a sleep disorder that is not insomnia.You have a serious mental health condition that could make it difficult or unsafe for you to take part in the study, like severe depression or thoughts of harming yourself.My liver or kidney function is not normal.You work during the night.
- Group 1: CBD
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any additional investigations involving Cannabidiol oral solution?
"Currently, 79 clinical trials related to Cannabidiol oral solution are underway. Of these 16 studies have reached the Phase 3 stage of testing. Most of the research sites for this medication are situated in Ribeirao Preto, Sao Paulo; yet a total 289 study locations exist throughout the world."
Is it possible to volunteer for this experimentation currently?
"This research venture is no longer enrolling participants; it was first announced on January 1st, 2022 and last amended on December 3rd 2021. If you are seeking other clinical trials, 134 studies are presently in search of patients with parasomnias while 79 investigations focus on Cannabidiol oral solution admission."
What is the purpose of this research endeavor?
"The primary endpoint of this trial, to be evaluated at baseline and after the 4 week medication phase, is Change in sleep latency as measured by wrist-worn actigraphy. Secondary measures include Neurocognitive function (Change in a summary score based on demographically adjusted neuropsychological tests), Sleep Quality (Pittsburgh Sleep Quality Index scores ranging from 0 to 21) and Neurocognitive Function T-scores between 1-100)."
How many subjects are included in the scope of this clinical investigation?
"At present, this medical trial is not open for recruitment. It was initially posted on the 1st of January 2022 and last edited on December 3rd 2021. There are currently 134 studies seeking individuals with parasomnias and 79 trials searching for participants to partake in Cannabidiol oral solution experiments that are actively recruiting patients."
Is the ingestion of Cannabidiol oral solution associated with any adverse effects?
"There is data indicating Cannabidiol's safety, but no evidence that it has any efficacy; this earns the drug a rating of 2 on our 1-3 scale."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger